Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.8.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Nov. 14, 2017
Jun. 24, 2016
Dec. 20, 2013
Mar. 31, 2017
Jan. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]              
Lease payments           $ 3,876 $ 5,375
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]              
Monthly lease payments $ 12,088         11,042  
Lease payments             33,126
Property taxes paid           12,712 12,167
Brad A. Sealfon [Member]              
Officer compensation       $ 2,000 $ 5,184    
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]              
Amortization of deferred compensation cost           0 7,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]              
Number of shares issued upon agreement     420,000        
Share price (in dollars per share)     $ 0.20        
Agreement term     3 years        
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]              
Monthly payment for agreement   $ 16,000          
Officer compensation           $ 0 $ 16,000